Abstract
Background
Intergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of adjuvant postoperative chemoradiotherapy, has demonstrated significant benefit.
Methods
We prospectively captured complete surgical information, including the treatment of various lymph node stations, for 553 of the 556 eligible participants in this trial. Before any survival analysis, we coded D level by using the Japanese general rules and used the Maruyama program to estimate the likelihood of disease in undissected regional node stations, defining the sum of these estimates as the Maruyama Index of Unresected Disease (MI). We analyzed survival with Cox multivariate regression.
Results
Fifty-four percent of participating patients underwent D0 lymphadenectomy. The median MI was 70 (range, 0–429). In contrast to D level, MI proved to be an independent prognostic factor, even with adjustment for the potentially linked variables of T stage and number of positive nodes. We detected no significant interaction between surgical or pathologic variables and the favorable effect of adjuvant treatment, but the power to detect such interaction was generally low.
Conclusions
MI, a measure of unresected regional nodal disease in gastric cancer, proved an independent predictor of survival. Surgical undertreatment, as observed in this trial, clearly undermined survival.
Similar content being viewed by others
References
Parkin DM, Pisani P, Ferlay J. Global cancer statistics.CA Cancer J Clin 1999;49:33–64.
Greenlee RT, Hill-Harmon MB, Taylor M, Thun M. Cancer statistics, 2001.CA Cancer J Clin 2001;51:15–36.
Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.Lancet 1969;2:865–7.
Gastrointestinal Tumor Study Group. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma.Cancer 1982;49:1771–7.
Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the somach or gastroesophageal junction.N Engl J Med 2001; 345:725–30.
American Joint Committee on Cancer.Manual for Staging of Cancer, 3rd ed., Philadelphia: Lippincott, 1988.
Nishi M, Omori Y, Miwa K, eds.Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara & Co Ltd, 1995.
Kampschoer GHM, Maruyama K, Van de Velde CJH, Sasako M, Kinoshita T, Okabayashi K. Computer analysis in making preopcrative decisions: a rational approach to lymph node dissection in gastric cancer patients.Br J Surg 1989;76:905–8.
Bollschweiler E, Boettcher K, Hoelscher AH, et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program.Br J Surg 1992;79:156–60.
American Joint Committee on Cancer.Manual for Staging of Cancer. 5th ed. Philadelphia: Lippincott, 1997.
Cox DR. Regression models and life tables.J R Stat Soc B 1972;34:187–220.
Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the ‘different disease’ hypothesis.Cancer 2000;88:921–32.
Estes NC, Macdonald JS, Touijer K, Benedetti J, Jacobson J. Inadequate documentation and resection for gastric cancer in the United States: a preliminary report.Am Surg 1998;64:680–5.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach—a patient care evaluation study by the American College of Surgeons.Ann Surg 1993;218:583–92.
Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival?J Am Coll Surg 1996;183:616–24.
Brennan MF. Radical surgery for gastric cancer. A review of the Japanese experience.Cancer 1989;64:2063.
Fielding JWL. Gastric cancer: different diseases.Br J Surg 1989; 76:1227.
Douglas HO. R2 dissection in the treatment of gastric malignancy.Surg Oncol Clin North Am 1993;2:413–31.
Dent DM, Madden MV, Price SK. Randomized comparison of R-1 and R-2 gastrectomy for gastric carcinoma.Surg Oncol Clin North Am 1993;2:433–41.
Hundahl SA. Gastric cancer nodal metastases: biologic significance and therapeutic considerations.Surg Oncol Clin North Am 1996;5:129–44.
Bonenkamp JJ, Hermans J, Sasako M, Van de Velde CJH. Extended lymph nodded dissection for gastric cancer.N Engl J Med 1999;340:908–14.
Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D-1 and D-2 resections for gastric cancer: long-term results of the MRC randomized surgical trial.Br J Cancer 1999;79:1522–30
Robertson CS, Chung SCS, Woods SDS, et al. A prospective randomized trial comparing R-1 subtotal gastrectomy with R-3 total gastrectomy for antral cancer.Ann Surg 1994;220:176–82.
Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter, randomized Italian trial.Ann Surg 1999;230:170–8.
Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial.Br J Surg 1997;84:1567–71.
Bonenkamp JJ, Songun I, Hermans J, et al. Randomized comparison of morbidity after D1 and D2 dissections for gastric cancer in 996 Dutch patients.Lancet 1995;345:745–8.
Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial.Lancet 1996;347:995–9.
Brennan MF. Lymph node dissection for gastric cancer.N Engl J Med 1999;340:956–8.
Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques are a source of misleading statistics for survival in cancer.N Engl J Med 1985; 312:1604–8.
Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer.World J Surg 1995;19:532–6.
McCulloch P. Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980–1985.Br J Surg 1994;81:417–20.
Siewert JR, Kelsen D, Maruyama K, et al.Gastric Cancer Diagnosis and Treatment—An Interactive Training Program. Version 1.0. CD-ROM. Heidelberg: Springer Electronic Media, 2000.
Cady B. Fundamentals of contemporary surgical oncology: biologie principles and the threshold concept govern treatment and outcomes.J Am Coll Surg 2001;192:777–92.
Kelsen DP. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 0116.J Clin Oncol 2000;18(21 Suppl):32S-34S.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Hundahl, S.A., Macdonald, J.S., Benedetti, J. et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Annals of Surgical Oncology 9, 278–286 (2002). https://doi.org/10.1007/BF02573066
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02573066